Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma

doi:10.3748/wjg.v24.i10.1120

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6850)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-3) series.

Item

Count

PDF

474

WORD

216

HTML

4039

Figures (1-7)

220

Tables (1-3)

156

Sum=5105

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

798

Download

947

Sum=1745

Mar 14, 2018 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Mar 14, 2018; 24(10): 1120-1133
Published online Mar 14, 2018. doi: 10.3748/wjg.v24.i10.1120

Full Size Figure Download Figure

Figure 1 The expression level of proteinase-activated receptor 2 predicts overall survival and disease-free survival in hepatocellular carcinoma patients. A: Immunohistochemical staining for proteinase-activated receptor 2 (PAR2) in hepatocellular carcinoma (HCC) tissues, and the expression level of PAR2 was divided into high (left) and low (right); B: Disease-free survival in HCC patients correlated with PAR2 expression; C: Overall survival in HCC patients correlated with PAR2 expression.

Citation: Sun L, Li PB, Yao YF, Xiu AY, Peng Z, Bai YH, Gao YJ. Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma. World J Gastroenterol 2018; 24(10): 1120-1133
URL: https://www.wjgnet.com/1007-9327/full/v24/i10/1120.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i10.1120